Dev
mRNA Vaccines Overcome Immunity Durability Challenges, Maintaining Antibody Response for 500 Days
A study published in *Nature Immunology* reveals that combining mRNA vaccines with a novel glycan adjuvant can significantly extend immune durability and mitigate the limitations of antigen imprinting.